The complement-mediated hemolytic assay was used to determine the efficacy of Efb-C on blocking classical complement activation as our previous report 2 .
Real-time PCR
Total RNA was extracted from MC3T3-E1 or RAW264.7 cells using Trizol reagent (Invitrogen) according to the manufacturer's instructions. Then the Reverse Transcription System (Promega, Inc.) was used to synthesize cDNA from total RNA. Real-time PCR amplification was performed with SYBR Green Master Mix (Invitrogen) and gene-specific primers. The endogenous gene β-actin was regarded as an internal. All primer sequences are specified in online supplementary table S1.
Western blot analysis
Western blot was performed according to the standard process. 
ELISA
Antibody titers against Efb-C in PG-immunized mouse serum were determined by an ELISA assay. Briefly，the test was performed on 96-well microplates coated with recombinant Efb-C protein at 250ng/100μl/well. After incubation with serum samples at 37°C for 1 hour, the plate was washed by PBST 5 times.
Then the goat anti-mouse secondary antibody conjugated with horseradish peroxidase was added. The color was developed using chromogenic substrate tetramethylbenzidine (TMB) and stopped at 10min using the stop solution, and read using a Synergy H4 Multi-Mode Microplate reader (Biotek, Inc., Winooski, VT) set to 450nm. 
